|Maine Medicine Weekly Update
October 31, 2021
US FDA & CDC Officially Expand Eligibility Recommendations For COVID-19 Booster Shots
The FDA, on October 20th, amended the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose for COVID-19 vaccines in eligible populations. A day later, the CDC endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of COVID-19 vaccines in certain populations.
For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot at 6 months or more after their initial series:
For the nearly 15 million people who got the Johnson & Johnson COVID-19 vaccine, booster shots are also recommended for those who are 18 and older and who were vaccinated two or more months ago.
Maine CDC guidance and FAQs on expansion of eligibility for COVID-19 Booster Shots – October 22, 2021
According to the US CDC, “available data right now show that all three of the COVID-19 vaccines approved or authorized in the United States continue to be highly effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant.”
FDA Action on Booster Doses – October 20, 2021
CDC Expands Eligibility for COVID-19 Booster Shots – October 21, 2021
The US Centers for Disease Control and Prevention (CDC) conducted a Clinician Outreach and Communication Activity (COCA) call on October 26th.
Updated Fact Sheets:
< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'email@example.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©